Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ · Healthcare
Harmony Biosciences Holdings, Inc. Long Term Debt 2020–2025
Harmony Biosciences Holdings, Inc. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Harmony Biosciences Holdings, Inc. long term debt as of December 31, 2025: 143.7M, a 11.87% decrease year-over-year.
- Harmony Biosciences Holdings, Inc. long term debt for 2025 were 143.7M, a 11.87% decrease from 2024.
- Harmony Biosciences Holdings, Inc. long term debt for 2024 were 163.0M, a 8.71% decrease from 2023.
- Harmony Biosciences Holdings, Inc. long term debt for 2023 were 178.6M, a 5.84% decrease from 2022.
- Harmony Biosciences Holdings, Inc. long term debt for 2022 were 189.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Harmony Biosciences Holdings, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $144 |
| 2024 | $163 |
| 2023 | $179 |
| 2022 | $190 |
| 2021 | $190 |
| 2020 | $194 |
Harmony Biosciences Holdings, Inc. Long Term Debt — FAQ
Harmony Biosciences Holdings, Inc. (HRMY) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see HRMY's long term debt history?
The chart and table above show Harmony Biosciences Holdings, Inc.'s long term debt by year and by quarter, including the growth rate.